Kurt Orlofski

Kurt Orlofski has an extensive work experience in the pharmaceutical industry. Kurt began their career in 1996 as VP and CFO at Faulding and later served as VP and General Manager at the same company. Kurt also held roles as Director at Marketing Financial Services and VP and General Manager at US Generics. In 2001, they joined Alpharma as SVP of Business Development and later became VP of Operations. Kurt also worked at Global Business Development as SR VP, where they managed all areas of business development and competitive intelligence. From 2004 to 2006, they served as President and CEO at Pliva, Inc, and achieved significant accomplishments such as increasing sales and market share, clearing a warning letter, and executing business development deals. Kurt then worked as President and CEO at Wockhardt USA, Inc from 2007 to 2009. Most recently, they have been the CEO of Pharmaceutical Associates Inc since 2017.

Kurt Orlofski completed their Bachelor of Science degree in Accounting and Computer Science from Rutgers University from 1985 to 1989. Kurt later pursued a Master of Business Administration (MBA) in Finance from Fairleigh Dickinson University from 1990 to 1992.